Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Tobacco Control 2006;15:64-67; doi:10.1136/tc.2005.013011
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNeill, A
Right arrow Articles by West, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeill, A
Right arrow Articles by West, R

BRIEF REPORT

Levels of toxins in oral tobacco products in the UK

A McNeill1, R Bedi2, S Islam2, M N Alkhatib2, R West1

1 Department of Epidemiology and Public Health, University College London, London, UK
2 Department of Dental Public Health, King’s College London, London, UK

Correspondence to:
Professor Raman Bedi
Department of Dental Public Health, King’s College London, Floor 2, Caldecot Road, Denmark Hill, Campus, London SE5 9RW, UK; r.bedi{at}eastman.ucl.ac.uk


ABSTRACT
Objective: This study examined the constituents of smokeless tobacco products available in the UK and compared them with products available in India, Sweden, and the USA

Methods: Seven UK brands of smokeless tobacco, including a tooth cleaning powder, and four international brands of smokeless tobacco were tested for a range of toxins and known carcinogens, such as tobacco specific N-nitrosamines (TSNA), as well as nicotine availability.

Results: Ten of the 11 brands tested had detectable levels of tobacco specific nitrosamines, which are proven carcinogens, and levels varied 130-fold. All had detectable levels of benzo(a)pyrene, another proven carcinogen (with around 175-fold variation) and several toxic metals (with nearly 150-fold variation). Nicotine availability varied in the UK products from 0.1 mg/g to 63.2 mg/g. All the tobacco products tested are likely to be hazardous to users’ health, but the data indicate that it should be possible to reduce key toxins to non-detectable levels.

Conclusions: Smokeless tobacco products should be regulated and standards set for maximum levels of toxins and carcinogens.


Abbreviations: BaP, benz(a) pyrene; NAB, N-nitrosoanabasine; NAT, N-nitrosoanatabine; NDMA, N-nitrosodimethylamine; NNK, 4(methylnitrosamino)-1-(3-pyridyl)–butanone; NNN, N-nitrosonornicotine; TSNA, tobacco specific nitrosamine

Keywords: smokeless tobacco; tobacco toxins; transcultural tobacco products; toxin standards




This article has been cited by other articles:


Home page
Br Med BullHome page
R. West
Tobacco control: present and future
Br. Med. Bull., November 14, 2006; (2006) ldl012v1.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
H. Marcovitch
What's new this month in BMJ Journals
BMJ, April 15, 2006; 332(7546): 904 - 904.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.